You are here

A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35294 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Fibromyalgia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients who met the American College of Rheumatology (ACR) criteria for fibromyalgia
(ie, widespread pain present for at least 3 months, and pain in at least 11 of 18
specific tender point sites)

- Patients who completed at least 4 pain diaries within the last 7 days and the average
pain score must have been ≥4, and had a score of ≥40 mm on the Visual Analogue Scale
(VAS) of the SF-MPQ at screening (Visit 1) and randomization (Visit 2)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with other severe pain that may confound assessment or self-evaluation of the
pain associated with fibromyalgia

- Patients with any inflammatory muscle or rheumatologic disease other than
fibromyalgia, active infections, or untreated endocrine disorders

- Patients with severe depression

NCT00645398
Pfizer
Completed
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Fibromyalgia
NCT00151489
All Genders
18+
Years
Multiple Sites
Fibromyalgia
NCT00607256
All Genders
18+
Years
Multiple Sites
Epilepsy, Neuropathic Pain, Fibromyalgia, Post-market Surveillance
NCT01220180
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now